Sharon Arrol
About Sharon Arrol
Sharon Arrol's Biopharmaceutical Industry Experience
Sharon Arrol, Ph.D., has over 20 years of experience in the biopharmaceutical industry. Her extensive career focuses on leading the development and validation of immunoassays. Most recently, she served as Director of Bioanalytical Development in the R&D department at Alexion AstraZeneca Rare Disease, where she supervised a team of scientists. Prior to this role, she worked at Pfizer as a principal scientist in the GLP Bioanalytical Group, managing the critical reagent group.
Sharon Arrol's Role at Alexion AstraZeneca
In her most recent role, Sharon Arrol served as Director of Bioanalytical Development for Alexion AstraZeneca Rare Disease. She was responsible for overseeing a team of scientists in the R&D department. Her work focused on bioanalytical development and involved significant leadership in the immunoassay development process.
Sharon Arrol's Career at Pfizer
Before joining Alexion, Sharon Arrol worked at Pfizer as a principal scientist in the GLP Bioanalytical Group. She managed the critical reagent group, contributing significantly to the field of bioanalysis. Her tenure at Pfizer included a range of responsibilities that underscored her expertise in managing and leading scientific teams.
Sharon Arrol's Education and Qualifications
Sharon Arrol earned a B.Sc. (Hons) in Biochemistry from Glasgow College of Technology. She further pursued her academic interests and attained a Ph.D. in Biochemistry from the University of Manchester, UK. This robust educational background has provided a solid foundation for her career in the biopharmaceutical industry.
Sharon Arrol's Interests and Personal Life
Outside of her professional life, Sharon Arrol enjoys vacationing in sunny locations with white sandy beaches. She has a passion for music and recently attended a concert by PINK. Supporting sports teams like the New York Yankees and Manchester City, she finds balance between her professional and personal interests.